Regarding other renal cell carcinomas, high STING mRNA levels and high immunohistochemical cytoplasmic expression of STING have been reported in renal medullary renal cell carcinoma [14], supporting further studies assessing the role of the cGAS-STING pathway in the immunotherapy of this tumor. This evidence concerns the gene CGAS and neoplasm.